[go: up one dir, main page]

DK212689A - Gabapentinmonohydrat og fremgangsmaade til fremstilling deraf - Google Patents

Gabapentinmonohydrat og fremgangsmaade til fremstilling deraf Download PDF

Info

Publication number
DK212689A
DK212689A DK212689A DK212689A DK212689A DK 212689 A DK212689 A DK 212689A DK 212689 A DK212689 A DK 212689A DK 212689 A DK212689 A DK 212689A DK 212689 A DK212689 A DK 212689A
Authority
DK
Denmark
Prior art keywords
gabapentin
procedures
preparing
mono hydrate
novel
Prior art date
Application number
DK212689A
Other languages
English (en)
Other versions
DK212689D0 (da
DK175400B1 (da
Inventor
Donald Eugene Butler
Barbara Jean Greenman
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22694659&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK212689(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of DK212689D0 publication Critical patent/DK212689D0/da
Publication of DK212689A publication Critical patent/DK212689A/da
Priority to DK200200056A priority Critical patent/DK175127B1/da
Application granted granted Critical
Publication of DK175400B1 publication Critical patent/DK175400B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/28—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK198902126A 1988-05-02 1989-05-01 Gabapentin, monohydrat DK175400B1 (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK200200056A DK175127B1 (da) 1988-05-02 2002-01-15 Gabapentin monohydrat og fremgangsmåde til fremstilling deraf

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18881988 1988-05-02
US07/188,819 US4894476A (en) 1988-05-02 1988-05-02 Gabapentin monohydrate and a process for producing the same

Publications (3)

Publication Number Publication Date
DK212689D0 DK212689D0 (da) 1989-05-01
DK212689A true DK212689A (da) 1989-11-03
DK175400B1 DK175400B1 (da) 2004-09-27

Family

ID=22694659

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198902126A DK175400B1 (da) 1988-05-02 1989-05-01 Gabapentin, monohydrat

Country Status (12)

Country Link
US (1) US4894476A (da)
EP (1) EP0340677B1 (da)
JP (1) JP2619951B2 (da)
AT (1) ATE101116T1 (da)
AU (1) AU624130B2 (da)
CA (1) CA1306755C (da)
DE (1) DE68912819T2 (da)
DK (1) DK175400B1 (da)
ES (1) ES2061774T3 (da)
FI (1) FI892067L (da)
HK (1) HK1000798A1 (da)
IE (1) IE62958B1 (da)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3928182A1 (de) * 1989-08-25 1991-02-28 Goedecke Ag Verfahren zur herstellung von gabapentin
PH27359A (en) * 1989-08-25 1993-06-21 Warner Lambert Co Process for cyclic amino acid anticonvulsant compounds
DE3928183A1 (de) * 1989-08-25 1991-02-28 Goedecke Ag Lactamfreie cyclische aminosaeuren
DE3928184A1 (de) * 1989-08-25 1991-02-28 Goedecke Ag Verfahren zur herstellung von cyclischen aminosaeurederivaten sowie zwischenprodukte
EP0458751A1 (en) * 1990-05-25 1991-11-27 Warner-Lambert Company Delivery system for cyclic amino acids with improved taste, texture and compressibility
IL125544A (en) * 1996-03-14 2002-03-10 Warner Lambert Co Transformed cyclic amino acids and pharmaceutical preparations containing them
US6372792B1 (en) 1996-04-26 2002-04-16 Guy Chouinard Method for treating anxiety, anxiety disorders and insomnia
US6255526B1 (en) 1996-12-24 2001-07-03 Teva Pharmaceutical Industries Ltd. Preparation of gabapentin
WO1999018063A2 (en) 1997-10-07 1999-04-15 Warner-Lambert Company Process for preparing a cyclic amino acid anticonvulsant compound
ES2137137B1 (es) 1998-05-25 2000-08-16 Medichem Sa Nuevo polimorfo de gabapentina no hidratada, su procedimiento de obtencion y su utilizacion para la obtencion de gabapentina de calidad farmaceutica.
ITMI981535A1 (it) * 1998-07-03 2000-01-03 Zambon Spa Processo per la preparazione di gabapentina
HU225502B1 (en) * 1998-12-29 2007-01-29 Richter Gedeon Vegyeszet Process for producing 1-(amino-metyl)-cyclohexene-acetic-acid and intermediates
IT1311984B1 (it) 1999-03-26 2002-03-22 Bioindustria Lab Italiano Medi Procedimento per la preparzione di gabapentin.
DE60022333T2 (de) * 1999-04-09 2006-07-06 Euro-Celtique S.A. Natrium kanalblocker zusammensetzungen und deren verwendung
ES2164527B1 (es) * 1999-04-26 2003-04-01 Medichen S A Procedimiento de obtencion de gabapentina de calidad farmaceutica.
US6294198B1 (en) 1999-08-24 2001-09-25 Purepac Pharmaceutical Co. Pharmaceutical tablet formulation containing gabapentin with improved physical and chemical characteristics and method of making the same
US6333352B1 (en) 2000-04-05 2001-12-25 Mimicking Man Manually, Inc. Method of treating benign positional vertigo
CZ200339A3 (cs) * 2000-06-16 2003-06-18 Teva Pharmaceutical Industries Ltd. Stabilní gabapentin vykazující neutrální pH
DK1289364T3 (da) * 2000-06-16 2004-04-13 Teva Pharma Stabil gapapentin som indeholder mere end 20 ppm chlorioner
EP1384473A1 (en) * 2000-06-16 2004-01-28 Teva Pharmaceutical Industries Ltd. Stable gabapentin containing more than 20 ppm of chlorine ion
ITMI20011132A1 (it) 2001-05-29 2002-11-29 Procos Spa Procedimento per la preparazione dell'acido 1-amminometil-1-cicloesanacetico
RU2295337C2 (ru) * 2001-09-03 2007-03-20 Ньюрон Фармасьютикалс Спа Фармацевтическая композиция, содержащая габапентин или его аналог и альфа-аминоамид, и ее применение в качестве анальгетика
US6800782B2 (en) * 2001-10-09 2004-10-05 Warner-Lambert Co. Anhydrous crystalline forms of gabapentin
US20060159743A1 (en) * 2001-10-25 2006-07-20 Depomed, Inc. Methods of treating non-nociceptive pain states with gastric retentive gabapentin
TWI312285B (en) 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
US7612112B2 (en) 2001-10-25 2009-11-03 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
US20070184104A1 (en) * 2001-10-25 2007-08-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
US20030119908A1 (en) * 2001-12-21 2003-06-26 Zambon Group S.P.A. Stable gabapentin compositions
US6682759B2 (en) 2002-02-01 2004-01-27 Depomed, Inc. Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
US7217696B2 (en) 2002-02-28 2007-05-15 A & D Bioscience, Inc. Glycuronamides, glycosides and orthoester glycosides of fluoxetine, analogs and uses thereof
WO2003079980A2 (en) * 2002-03-19 2003-10-02 A & D Bioscience, Inc. Caboxylic acid glycuronides, glycosamides and glycosides of quinolones, penicillins, analogs, and uses thereof
WO2003086475A1 (en) * 2002-04-12 2003-10-23 A & D Bioscience, Inc. Conjugates comprising cancer cell specific ligands, a sugar and diagnostic agents, and uses thereof
EP1494996A1 (en) * 2002-04-16 2005-01-12 Taro Pharmaceutical Industries Limited Process for preparing gabapentin
US20050153928A1 (en) * 2002-05-07 2005-07-14 Holick Michael F. Conjugates comprising a central nervous system-active drug linked to glucuronic acid or glucosamine through an amide bond and uses thereof
US20050215487A1 (en) * 2002-06-27 2005-09-29 Holick Michael F Conjugates comprising an nsaid and a sugar and uses thereof
US7196216B2 (en) * 2002-11-18 2007-03-27 Nicholas Piramal India Limited Process for preparation of Gabapentin
US20040214893A1 (en) * 2003-04-11 2004-10-28 Matthew Peterson Gabapentin compositions
EP1615875A2 (en) * 2003-04-21 2006-01-18 Matrix Laboratories Limited Process for the preparation of gabapentin form-ii
US20070043236A1 (en) * 2003-05-19 2007-02-22 Chandiran Thakashina M Process for preparation of gabapentin
WO2004106281A1 (en) * 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Crystalline gabapentin
US20050013863A1 (en) 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
US20050187295A1 (en) * 2004-02-19 2005-08-25 Surendra Kalyan Processes for the preparation of gabapentin
ITMI20040579A1 (it) * 2004-03-25 2004-06-25 Zambon Spa Processo di preparazione di gabapentina
GB0416228D0 (en) 2004-07-20 2004-08-25 Sandoz Ind Products S A Process for the preparation of gabapentin
PT1809271E (pt) * 2004-09-10 2010-08-30 Newron Pharm Spa Utilização de (halogenobenziloxi)benzilamino-propanamidas para o fabrico de medicamentos activos como moduladores selectivos dos canais de sódio e/ou de cálcio
ITMI20042418A1 (it) * 2004-12-17 2005-03-17 Zambon Spa Processo per la purificazione della gabapentina
US7071356B1 (en) * 2005-12-01 2006-07-04 Isp Investments Inc. Process for the preparation of 1-(aminomethyl) cyclohexaneacetic acid
US20090176882A1 (en) 2008-12-09 2009-07-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
RU2464023C2 (ru) * 2008-05-16 2012-10-20 АКСИС, Инс Лекарственное средство для лечения фибромиалгии
US8431739B2 (en) 2010-06-14 2013-04-30 Divi's Laboratories, Ltd. Process for the preparation of gabapentin
EP2923694B1 (en) 2014-03-27 2018-11-14 Sanovel Ilac Sanayi ve Ticaret A.S. Oral liquid pharmaceutical solution of gabapentin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087544A (en) * 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
DE2460891C2 (de) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US4014175A (en) * 1975-05-05 1977-03-29 Brink Douglas F Cable and pipe laying machine
US4087594A (en) * 1977-03-21 1978-05-02 Gte Laboratories, Incorporated Reactivation of primary electrochemical cells
PH27359A (en) * 1989-08-25 1993-06-21 Warner Lambert Co Process for cyclic amino acid anticonvulsant compounds

Also Published As

Publication number Publication date
FI892067A0 (fi) 1989-04-28
US4894476A (en) 1990-01-16
AU3267889A (en) 1989-11-02
ES2061774T3 (es) 1994-12-16
DE68912819D1 (de) 1994-03-17
ATE101116T1 (de) 1994-02-15
AU624130B2 (en) 1992-06-04
FI892067L (fi) 1989-11-03
JPH0211546A (ja) 1990-01-16
IE891142L (en) 1989-11-02
EP0340677A3 (en) 1990-12-27
CA1306755C (en) 1992-08-25
JP2619951B2 (ja) 1997-06-11
DK212689D0 (da) 1989-05-01
HK1000798A1 (en) 1998-05-01
IE62958B1 (en) 1995-03-08
DE68912819T2 (de) 1994-05-19
EP0340677B1 (en) 1994-02-02
DK175400B1 (da) 2004-09-27
EP0340677A2 (en) 1989-11-08

Similar Documents

Publication Publication Date Title
DK212689A (da) Gabapentinmonohydrat og fremgangsmaade til fremstilling deraf
AU3105793A (en) Process for purifying acrylic acid in high purity in the production of acrylic acid
IS2877A7 (is) Aðferð til að framleiða hreinan kísilmálm
DE3688009D1 (de) Verfahren zum herstellen von kieselsaeure hoher reinheit.
GB8823220D0 (en) Thin film transistors & process for making such transistors
AU587308B2 (en) Process for the production of synthesis gas
IL110861A0 (en) Process for preparing pure ethylenediaminetetra (methylenephosphonic acid)
IT9083313A1 (it) Processo per la produzione di perossido di idrogeno (ii)
AU1404688A (en) Process for recovery of gallium by chelate resin
EG17867A (en) Process for the preparation of optically pure compound
AU582172B2 (en) Process for producing alcohols from synthesis gas
AU649632B2 (en) Process for the synthesis of cyclic polynitrogenated compounds
ATE218131T1 (de) Verfahren zur herstellung von mono-n- substituierten tetraazamakrocyclen
HU9301020D0 (en) Method for producing optically active cyanohydrides by means of enzymatic reaction
FI103804B1 (fi) Menetelmä tetrahydrofotolaattiyhdisteiden optisesti puhtaiden diastereoisomeerien valmistamiseksi
EP0603671A3 (de) Verfahren zur Reaktivierung von gereinigten Membranproteinen.
EP0137289A3 (en) Process for the preparation of silica polymorphs from silicon
AU5299490A (en) Process for synthesis of acylamino silicon compounds
AU2038988A (en) A process for the manufacture of novel unsaturated amino acid compounds
IT1190116B (it) Processo per la sintesi di mono o di idrossifluoroalcani
DE59307005D1 (de) Verfahren zur Herstellung von Ph3C[B(C6F5)4]
AU568694B2 (en) N-benzyl-n-phenyl-b-pyrrolidinyl-f-isobutoxy-propylamine
AU8066387A (en) Process for fertilisation of vineyards
HU206395B (en) Process for producing chrome-free soft leather
MY110724A (en) Process for converting loracarbef dihydrate to loracarbef monohydrate

Legal Events

Date Code Title Description
PUP Patent expired